Bicycle Therapeutics plcBCYCNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank25
3Y CAGR-33.3%
5Y CAGR-27.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-33.3%/yr
vs +13.3%/yr prior
5Y CAGR
-27.5%/yr
Recent deceleration
Acceleration
-46.6pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 10.52% |
| 2023 | 91.76% |
| 2022 | 81.84% |
| 2021 | 35.39% |
| 2020 | 4.77% |
| 2019 | 52.40% |
| 2018 | 74.96% |
| 2017 | 21.44% |
| 2016 | 0.00% |